Lantern Pharma Inc
(LTRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,390 | 6,061 | 6,378 | 7,511 | 8,103 |
| Marketable Securities | 3,973 | 9,840 | 13,344 | 16,502 | 19,951 |
| TOTAL | $13,461 | $17,201 | $20,823 | $25,248 | $29,921 |
| Non-Current Assets | |||||
| PPE Net | 36 | 40 | 44 | 47 | 49 |
| Other Non-Current Assets | 130 | 180 | 229 | 277 | 323 |
| TOTAL | $166 | $220 | $273 | $324 | $372 |
| Total Assets | $13,627 | $17,420 | $21,096 | $25,572 | $30,293 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,946 | 4,753 | 4,125 | 4,140 | 3,404 |
| TOTAL | $4,040 | $4,884 | $4,286 | $4,331 | $3,601 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 14 | 33 | 53 | 94 |
| TOTAL | $N/A | $14 | $33 | $53 | $94 |
| Total Liabilities | $4,040 | $4,898 | $4,320 | $4,384 | $3,695 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,184 | 10,799 | 10,785 | 10,785 | 10,785 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -89,071 | -84,893 | -80,562 | -76,026 | -70,150 |
| Other shareholders' equity | 40 | 48 | 132 | 154 | -25 |
| TOTAL | $9,587 | $12,522 | $16,777 | $21,188 | $26,598 |
| Total Liabilities And Equity | $13,627 | $17,420 | $21,096 | $25,572 | $30,293 |